BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 8201263)

  • 1. Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis.
    Brewer GJ; Dick RD; Yuzbasiyan-Gurkan V; Johnson V; Wang Y
    J Lab Clin Med; 1994 Jun; 123(6):849-58. PubMed ID: 8201263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Wilson's disease with zinc. VI. Initial treatment studies.
    Brewer GJ; Yuzbasiyan-Gurkan V; Lee DY; Appelman H
    J Lab Clin Med; 1989 Dec; 114(6):633-8. PubMed ID: 2592853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
    Hoogenraad TU
    Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Wilson's disease with zinc: III. Prevention of reaccumulation of hepatic copper.
    Brewer GJ; Hill GM; Dick RD; Nostrant TT; Sams JS; Wells JJ; Prasad AS
    J Lab Clin Med; 1987 May; 109(5):526-31. PubMed ID: 3572199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
    Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc therapy in Wilson's disease: observations in five patients.
    Rossaro L; Sturniolo GC; Giacon G; Montino MC; Lecis PE; Schade RR; Corazza GR; Trevisan C; Naccarato R
    Am J Gastroenterol; 1990 Jun; 85(6):665-8. PubMed ID: 2353684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of Wilson's disease: results of a single center experience.
    Medici V; Trevisan CP; D'Incà R; Barollo M; Zancan L; Fagiuoli S; Martines D; Irato P; Sturniolo GC
    J Clin Gastroenterol; 2006; 40(10):936-41. PubMed ID: 17063115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper and zinc in the serum, urine, and hair of patients with Wilson's disease treated with penicillamine and zinc.
    Dastych M; Procházková D; Pokorný A; Zdrazil L
    Biol Trace Elem Res; 2010 Mar; 133(3):265-9. PubMed ID: 19562272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose zinc administration as an effective Wilson's disease treatment.
    Najda J; Stella-Hołowiecka B; Machalski M
    Biol Trace Elem Res; 2001 Jun; 80(3):281-4. PubMed ID: 11508632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Wilson's disease with zinc XVI: treatment during the pediatric years.
    Brewer GJ; Dick RD; Johnson VD; Fink JK; Kluin KJ; Daniels S
    J Lab Clin Med; 2001 Mar; 137(3):191-8. PubMed ID: 11241029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of zinc in the initial treatment of Wilson's disease in children].
    Cacić M; Percl M; Jadresin O; Kolacek S
    Lijec Vjesn; 2000 Mar; 122(3-4):77-81. PubMed ID: 10932534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
    Prasad R; Kaur G; Walia BN
    Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Wilson's disease with zinc: X. Intestinal metallothionein induction.
    Yuzbasiyan-Gurkan V; Grider A; Nostrant T; Cousins RJ; Brewer GJ
    J Lab Clin Med; 1992 Sep; 120(3):380-6. PubMed ID: 1517684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of treatment of Wilson's disease--own observations.
    Jabłońska-Kaszewska I; Drobińska-Jurowiecka A; Dabrowska E; Trocha H
    Med Sci Monit; 2003 Aug; 9 Suppl 3():9-14. PubMed ID: 15156603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Wilson's disease with zinc. IX: Response of serum lipids.
    Brewer GJ; Yuzbasiyan-Gurkan V; Johnson V
    J Lab Clin Med; 1991 Nov; 118(5):466-70. PubMed ID: 1940587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management.
    Gibbs K; Hanka R; Walshe JM
    Q J Med; 1978 Jul; 47(187):349-64. PubMed ID: 715173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and characterization of presymptomatic patients with Wilson's disease and the use of molecular genetics to aid in the diagnosis.
    Yuzbasiyan-Gurkan V; Johnson V; Brewer GJ
    J Lab Clin Med; 1991 Nov; 118(5):458-65. PubMed ID: 1940586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc and tetrathiomolybdate for the treatment of Wilson's disease and the potential efficacy of anticopper therapy in a wide variety of diseases.
    Brewer GJ
    Metallomics; 2009; 1(3):199-206. PubMed ID: 21305118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of copper determination in late onset of Wilson's disease.
    Lech T; Hydzik P; Kosowski B
    Clin Toxicol (Phila); 2007 Sep; 45(6):688-94. PubMed ID: 17849244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.